Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-167,142
| Closed | -$14.9M | – | 81 |
|
|
2023
Q4 | $14.9M | Hold |
167,142
| – | – | 1.02% | 34 |
|
|
2023
Q3 | $12.4M | Hold |
167,142
| – | – | 0.91% | 33 |
|
|
2023
Q2 | $13.9M | Hold |
167,142
| – | – | 0.98% | 33 |
|
|
2023
Q1 | $12.5M | Buy |
167,142
+139,645
| +508% | +$10.4M | 1.01% | 37 |
|
|
2022
Q4 | $2.27M | Hold |
27,497
| – | – | 0.19% | 81 |
|
|
2022
Q3 | $2.17M | Hold |
27,497
| – | – | 0.18% | 85 |
|
|
2022
Q2 | $2.03M | Hold |
27,497
| – | – | 0.16% | 85 |
|
|
2022
Q1 | $2.45M | Hold |
27,497
| – | – | 0.17% | 82 |
|
|
2021
Q4 | $3.08M | Hold |
27,497
| – | – | 0.2% | 88 |
|
|
2021
Q3 | $3.46M | Hold |
27,497
| – | – | 0.25% | 82 |
|
|
2021
Q2 | $3.72M | Buy |
27,497
+1,097
| +4% | +$149K | 0.27% | 80 |
|
|
2021
Q1 | $3.58M | Sell |
26,400
-1,097
| -4% | -$149K | 0.36% | 58 |
|
|
2020
Q4 | $3.87M | Buy |
27,497
+1,097
| +4% | +$154K | 0.36% | 60 |
|
|
2020
Q3 | $2.94M | Hold |
26,400
| – | – | 0.34% | 52 |
|
|
2020
Q2 | $2.96M | Hold |
26,400
| – | – | 0.43% | 51 |
|
|
2020
Q1 | $2.51M | Hold |
26,400
| – | – | 0.6% | 48 |
|
|
2019
Q4 | $2.51M | Buy |
26,400
+895
| +4% | +$85.1K | 0.58% | 50 |
|
|
2019
Q3 | $2.31K | Hold |
25,505
| – | – | 0.36% | 49 |
|
|
2019
Q2 | $2.31M | Hold |
25,505
| – | – | 0.65% | 44 |
|
|
2019
Q1 | $2.31M | Hold |
25,505
| – | – | 0.78% | 39 |
|
|
2018
Q4 | $1.83M | Buy |
+25,505
| New | +$1.83M | 0.59% | 44 |
|